- Home
- PCM vs FORA Comparison
PCM vs FORA Comparison
Compare PCM & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PCM | FORA |
|---|---|---|
| Founded | 1993 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.0M | 67.3M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | PCM | FORA |
|---|---|---|
| Price | $5.62 | $2.17 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 42.8K | ★ 47.4K |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | ★ 11.68% | N/A |
| EPS Growth | N/A | ★ 25.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $30,256,919.00 |
| Revenue This Year | N/A | $8.44 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 50.13 |
| 52 Week Low | $5.52 | $1.64 |
| 52 Week High | $6.76 | $2.71 |
Technical Indicators
Market Signals| Indicator | PCM | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 38.22 | 64.06 |
| Support Level | $5.52 | $2.05 |
| Resistance Level | $6.15 | $2.20 |
| Average True Range (ATR) | 0.12 | 0.01 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 5.00 | 66.67 |
Price Performance
Historical ComparisonAbout PCM PCM Fund Inc.
Pcm Fund Inc is a closed-end investment management company. Its investment objective is to seek current income as a primary focus and also capital appreciation. The Fund invests in agency-guaranteed mortgage-backed securities, private-label mortgage-backed securities, high-yield corporate debt securities, and commercial mortgage-backed securities.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.